Ninapharm
Ninapharm is a France-based private biotechnology company developing a combined microbiome and mitochondria energy technology platform aimed at supporting human longevity and healthy aging.
- Company typePrivate
- Founded1993
- HeadquartersAnnecy, France
- Headcount51–100
- GTM typeB2C
- OfferingServices
What Ninapharm does
Ninapharm is a France-based biotechnology company headquartered in Annecy, founded in 1993 and operating with a headcount in the 51-100 range. The company is positioned around a single integrated technology platform that combines microbiome science with mitochondria-targeted energy interventions, framed by the company as a longevity offering intended to support healthy aging and extended human lifespan. The company presents its offering through a corporate website with trilingual content (English, French, Japanese), a YouTube video, and a single branded product page describing the 'Microbiome + Mitochondria Longevity Technology' platform; no distinct modular products, pricing, certifications, regulatory clearances, partnerships, named customers, or pipeline assets are disclosed in the available source material.
The company's go-to-market, pricing model, and revenue mechanics are not described in the available sources. There is no disclosure of distribution channels, customer segments, sales motion, or commercial milestones, and the firmographic data does not include investors, funding rounds, M&A activity, leadership team, patents, regulatory actions, or geographic operating footprint. As a result, the available evidence supports only a limited description of the company's commercial posture: it appears to operate as a small, privately held French biotech with a narrow, longevity-themed technical focus and minimal public commercial disclosure.
Ninapharm firmographics
Firmographics- Name
- Ninapharm
- Website
- https://ninapharm.com
- Company type
- Private
- Founded year
- 1993
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Ninapharm is a France-based private biotechnology company developing a combined microbiome and mitochondria energy technology platform aimed at supporting human longevity and healthy aging.
- Ownership category
- akta.pro rank
Ninapharm industry classification
Industry- Product category
- Longevity Biotechnology
- akta.pro primary industry
- Healthy Aging & Longevity Lifestyle Coaching (HSADAGAK)
Keywords
Where Ninapharm is headquartered
LocationHeadquarters
- HQ city
- Annecy
- HQ country
- France
- HQ region
- Europe
Markets served
Ninapharm business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales
Ninapharm product offering
Product offeringCore offering
Ninapharm develops and provides a longevity technology platform that combines advanced Microbiome and Mitochondria energy technologies aimed at supporting healthy human aging and extending healthy lifespan. The offering is positioned as a unified science-based approach to cellular energy and gut microbiome health, with the stated consumer outcome of gracefully living to 100 years.
Product overview
Ninapharm is a longevity-focused pharmaceutical/biotechnology company pioneering human longevity through advanced Microbiome and Mitochondria energy technologies. Their core offering centers on a unified technology platform aimed at helping individuals gracefully live to 100 years. No distinct modular products, add-ons, or separate product lines are explicitly named in the available source material.
Differentiator
Problem solved
Functional benefit
Products and services
- Microbiome + Mitochondria Longevity Technology Advanced longevity technology platform combining microbiome and mitochondria energy solutions designed to support healthy aging and extend human lifespan to 100 years, targeted at individual consumers interested in proactive longevity.
Companies that use Ninapharm
Customer profileIdeal customer profiles1 record
Ninapharm technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Ninapharm partnerships and signals
Strategic signalRecent moves3 records
Expansion highlights2 records
Ninapharm competitors and assessment
Company assessmentDirect peers
- Elysium Health: Consumer-facing longevity biotech selling proprietary cellular health supplements (e.g., Basis with NAD+ precursors). Closely comparable to Ninapharm as a science-branded longevity product company targeting healthy aging through cellular/mitochondrial mechanisms.
- Life Extension: Long-established consumer longevity supplements company offering a wide catalog of anti-aging and cellular health products. Comparable to Ninapharm as a longevity-focused consumer health brand with international reach.
- Thorne HealthTech: Premium supplements and health testing company with strong scientific branding and partnerships (e.g., Mayo Clinic). Comparable to Ninapharm for its premium, science-led positioning in the consumer health/longevity space.
Emerging players
- ZOE: Personalized nutrition company built on microbiome science and metabolic testing, with consumer subscriptions for gut health programs. Comparable to Ninapharm specifically for its microbiome science foundation applied to consumer health.
- InsideTracker: Personalized health and longevity platform combining biomarker testing with supplement and lifestyle recommendations. Comparable for the consumer-facing intersection of biotech, personalized wellness, and healthy aging.
- Juvenescence: Longevity biotech developing a pipeline of therapeutics and consumer health products targeting aging biology. Comparable as a longevity platform company operating across multiple anti-aging mechanisms.
Broad incumbents
- Calico Life Sciences: Alphabet-backed longevity R&D organization with substantial funding and academic partnerships studying aging biology. Comparable as an incumbent longevity biotech working on cellular mechanisms of aging, though operating primarily in deep research rather than consumer products.
- Altos Labs: Well-funded longevity biotech focused on cellular rejuvenation biology, backed by multi-billion-dollar investment. Comparable as a major longevity biotech competitor with deep scientific resources, though more research-stage than Ninapharm's apparent consumer orientation.
Market position
Strengths3 records
Weaknesses3 records
Competitive moat1 record
Key risks5 records
Key highlights5 records
Customer concentration
Ninapharm social profiles
Digital presenceNinapharm financial estimates
Financial estimateRevenue estimate
Valuation estimate
Ninapharm leadership team
Management profileNumber of profiles
Ninapharm funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Ninapharm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Ninapharm
What does Ninapharm do?
Ninapharm develops and provides a longevity technology platform that combines advanced Microbiome and Mitochondria energy technologies aimed at supporting healthy human aging and extending healthy lifespan. The offering is positioned as a unified science-based approach to cellular energy and gut microbiome health, with the stated consumer outcome of gracefully living to 100 years.
Is Ninapharm a public or private company?
Ninapharm is a private company. It is classified as unknown and is currently operating.
When was Ninapharm founded?
Ninapharm was founded in 1993. It employs 51 to 100 people.
Where is Ninapharm based?
Ninapharm is headquartered in Annecy, France, in the Europe region.
Who are Ninapharm's main competitors?
Direct peers on record are Elysium Health, Life Extension and Thorne HealthTech. Emerging players are ZOE, InsideTracker and Juvenescence. Broad incumbents are Calico Life Sciences and Altos Labs.
Does Ninapharm have an API?
No public API is recorded for Ninapharm.
What industry is Ninapharm in?
Ninapharm's product category is Longevity Biotechnology. Its primary akta.pro industry code is HSADAGAK, Healthy Aging & Longevity Lifestyle Coaching.